The midterm results of coronary endarterectomy in patients with diffuse coronary artery disease

Zhibing Qiu1, L Auchoybur Merveesh1, Yueyue Xu1

  • 1Department of Thoracic and Cardiovascular Surgery. Nanjing First Hospital, Nanjing Medical University, Changle Rd 68, Nanjing, 210006, Jiangsu, China.

Insights

Coronary endarterectomy (CE) combined with CABG offers a safe revascularization option for diffuse coronary artery disease. Early and mid-term results show good graft patency, especially when CE is performed on the LAD with LIMA grafting.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Diffuse coronary artery disease presents challenges for traditional revascularization methods like PCI and CABG.
  • Coronary artery endarterectomy (CE) combined with CABG is explored as an alternative for complete revascularization.
  • Mid- and long-term outcomes of CE have been a subject of debate.

Purpose of the Study:

  • To evaluate the early and mid-term graft patency of concomitant coronary artery endarterectomy and CABG.
  • To assess the safety and feasibility of CE in patients with diffuse coronary artery disease.

Main Methods:

  • A retrospective analysis of 304 patients undergoing CE and CABG for diffuse coronary artery disease.
  • Inclusion criteria: complete records, good intraoperative graft flow, discharge, and 1- or 3-year follow-up.
  • Follow-up data collected via outpatient visits and telephone contact; statistical analysis using Chi-square and student's t-tests.

Main Results:

  • The study included 238 patients (269 target vessels), with a mean age of 67.8 years.
  • Overall graft patency was 78.4% at 1 year and 69.8% at 3 years.
  • Left coronary graft patency was higher than right; no significant difference between on-pump and off-pump CE+CABG. Predictors of better patency included LIMA graft, CE on LAD, and intra-operative graft flow parameters.

Conclusions:

  • Coronary endarterectomy (CE) is a safe and feasible option for select patients with diffuse coronary artery disease, demonstrating excellent mid-term survival and graft patency.
  • CE yields superior results when performed on the Left Anterior Descending (LAD) artery and grafted with the Left Internal Mammary Artery (LIMA).
  • Both on-pump and off-pump surgical approaches yield similar outcomes, positioning CE as a viable alternative for coronary artery reconstruction.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K